Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2010
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592318/
https://www.ncbi.nlm.nih.gov/pubmed/20532462
_version_ 1783262859808997376
collection PubMed
description
format Online
Article
Text
id pubmed-5592318
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-55923182017-09-29 Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®) Cardiovasc J Afr Cardiovascular Topics Clinics Cardive Publishing 2010-06 /pmc/articles/PMC5592318/ /pubmed/20532462 Text en Copyright © 2015 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
title Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
title_full Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
title_fullStr Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
title_full_unstemmed Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
title_short Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa®)
title_sort boehringer launches first direct thrombin inhibitor: dabigatran (pradaxa®)
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592318/
https://www.ncbi.nlm.nih.gov/pubmed/20532462

Ejemplares similares